SCHEMBL7229482

SCHEMBL7229482

N#Cc1cnc(Nc2ccc(C(F)(F)F)cn2)s1

nearest known ligand 0.58

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
KDR P35968 14/20 0.58
CCR6 P51684 1/20 0.39
TRPV1 Q8NER1 1/20 0.39
SCN9A Q15858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7237851 0.78 KDR (0.62) KDR
SCHEMBL7235297 0.78 KDR (0.62) KDR
SCHEMBL7235235 0.75 KDR (0.58) KDR
SCHEMBL7235024 0.74 KDR (0.65) KDR
SCHEMBL6179910 0.74 KDR (1.00) KDR
SCHEMBL15400995 0.73 TNNI3K (0.39) KDRCCR6
SCHEMBL5889065 0.72 KDR (1.00) KDR
SCHEMBL7235039 0.69 KDR (0.62) KDR
SCHEMBL7237790 0.69 KDR (0.64) KDR
SCHEMBL28944648 0.69 KDR (0.72) KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6586424-B2 Anticancer agents; anticholesterol agents MERCK & CO., INC. 2003-07-01 US disclosed
US-6586423-B2 2-(Pyridin-2-ylamino)-thiazole-5-carbonitrile derivatives; angiogenesis inhibitors; antitumor and anticarcinogenic agents; atherosclerosis, macular degeneration, diabetic retinopathy MERCK & CO., INC. 2003-07-01 US disclosed